A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Tolerability of Gabapentin Enacarbil in Subjects with Restless Legs Syndrome | Zendy

Daniel O. Lee | Zendy; Ronald B. Ziman | Zendy; Amanda Perkins | Zendy; J. Steven Poceta | Zendy; Arthur S. Walters | Zendy; Ronald W. Barrett | Zendy

Open Access

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Tolerability of Gabapentin Enacarbil in Subjects with Restless Legs Syndrome

Author(s) -

Daniel O. Lee,

Ronald B. Ziman,

Amanda Perkins,

J. Steven Poceta,

Arthur S. Walters,

Ronald W. Barrett

Publication year - 2011

Publication title -

journal of clinical sleep medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.529

H-Index - 92

eISSN - 1550-9397

pISSN - 1550-9389

DOI - 10.5664/jcsm.1074

Subject(s) - tolerability , placebo , medicine , restless legs syndrome , placebo controlled study , adverse effect , clinical global impression , randomized controlled trial , anesthesia , physical therapy , double blind , insomnia , psychiatry , alternative medicine , pathology

To evaluate the efficacy and tolerability of gabapentin enacarbil (GEn) 1200 mg or 600 mg compared with placebo in subjects with moderate-to-severe primary restless legs syndrome (RLS).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research